16 results on '"Raasveld, S. Jorinde"'
Search Results
2. Reduced anticoagulation targets in extracorporeal life support (RATE): study protocol for a randomized controlled trial
- Author
-
van Minnen, Olivier, Oude Lansink-Hartgring, Annemieke, van den Boogaard, Bas, van den Brule, Judith, Bulpa, Pierre, Bunge, Jeroen J. H., Delnoij, Thijs S. R., Elzo Kraemer, Carlos V., Kuijpers, Marijn, Lambermont, Bernard, Maas, Jacinta J., de Metz, Jesse, Michaux, Isabelle, van de Pol, Ineke, van de Poll, Marcel, Raasveld, S. Jorinde, Raes, Matthias, dos Reis Miranda, Dinis, Scholten, Erik, Simonet, Olivier, Taccone, Fabio S., Vallot, Frederic, Vlaar, Alexander P. J., and van den Bergh, Walter M.
- Published
- 2022
- Full Text
- View/download PDF
3. Bleeding assessment following central venous catheter placement, a direct comparison of prospective and retrospective analyses.
- Author
-
van Baarle, Floor L. F., van de Weerdt, Emma K., Raasveld, S. Jorinde, Vlaar, Alexander P. J., Biemond, Bart J., van der Velden, Walter J. F. M., Ruiterkamp, Roelof A., Tuinman, Pieter R., Ypma, Paula F., van den Bergh, Walter M., Demandt, Astrid M. P., Kerver, Emile D., Jansen, A. J. Gerard, Westerweel, Peter E., Arbous, M. Sesmu, Determann, Rogier M., van Mook, Walther N. K. A., Koeman, Mirelle, Mäkelburg, Anja B. U., and van Lienden, Krijn P.
- Subjects
CENTRAL venous catheterization ,CENTRAL venous catheters ,INTER-observer reliability ,ODDS ratio ,RETROSPECTIVE studies - Abstract
Background: Reported bleeding incidences following central venous catheter (CVC) placement highly depend on methods of bleeding assessment. To determine the direction and magnitude of the bias associated with retrospective data collection, we used data from the PACER randomized controlled trial and a previous retrospective cohort study. Study Design and Methods: A patient‐level comparison of CVC‐related bleeding severity was made among (1) the prospectively collected clinical bleeding assessment of the PACER trial, (2) centralized assessment of CVC insertion site photographs, and (3) retrospective chart review. Interrater reliability for photographic bleeding assessment and retrospective chart review was assessed using Cohen's κ. The magnitude of underreporting of both methods compared to prospective clinical bleeding assessment at different cutoff points of clinically relevant bleeding was assessed using McNemar's test. Results: Interrater reliability was acceptable for both methods (κ = 0.583 and κ = 0.481 for photographic assessment and retrospective chart review, respectively). Photographic bleeding assessment led to significant underreporting of bleeding complications at all cutoff points. Retrospective chart review led to significant underreporting of minor bleeding complications, with an odds ratio (95% CI) of 0.17 (0.044–0.51) for the cutoff point grade 1 (i.e., self‐limiting or requiring at most 20 min of manual compression) or higher. There was no significant underreporting of major bleeding complications with retrospective chart review. Discussion: Centralized photographic bleeding assessment and retrospective chart review lead to biased bleeding assessment compared to prospective clinical bleeding assessment. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Transfusion strategies in bleeding critically ill adults: a clinical practice guideline from the European Society of Intensive Care Medicine
- Author
-
Vlaar, Alexander P. J., Dionne, Joanna C., de Bruin, Sanne, Wijnberge, Marije, Raasveld, S. Jorinde, van Baarle, Frank E. H. P., and Antonelli, Massimo
- Subjects
John Wiley & Sons Inc. ,Task forces -- Usage ,Tranexamic acid -- Usage ,Medical research -- Usage ,Medicine, Experimental -- Usage ,Trade and professional associations -- Usage ,Biological products -- Usage ,Book publishing -- Usage ,Medical colleges -- Usage ,Adults -- Usage ,Evidence-based medicine -- Usage ,Health care industry - Abstract
Purpose To develop evidence-based clinical practice recommendations regarding transfusion practices and transfusion in bleeding critically ill adults. Methods A taskforce involving 15 international experts and 2 methodologists used the GRADE approach to guideline development. The taskforce addressed three main topics: transfusion support in massively and non-massively bleeding critically ill patients (transfusion ratios, blood products, and point of care testing) and the use of tranexamic acid. The panel developed and answered structured guideline questions using population, intervention, comparison, and outcomes (PICO) format. Results The taskforce generated 26 clinical practice recommendations (2 strong recommendations, 13 conditional recommendations, 11 no recommendation), and identified 10 PICOs with insufficient evidence to make a recommendation. Conclusions This clinical practice guideline provides evidence-based recommendations for the management of massively and non-massively bleeding critically ill adult patients and identifies areas where further research is needed., Author(s): Alexander P. J. Vlaar [sup.1], Joanna C. Dionne [sup.2] [sup.3] [sup.4] [sup.21], Sanne de Bruin [sup.1], Marije Wijnberge [sup.1] [sup.5], S. Jorinde Raasveld [sup.1], Frank E. H. P. van [...]
- Published
- 2021
- Full Text
- View/download PDF
5. Health-related quality of life, one-year costs and economic evaluation in extracorporeal membrane oxygenation in critically ill adults
- Author
-
Oude Lansink-Hartgring, Annemieke, primary, Miranda, Dinis Dos Reis, additional, Mandigers, Loes, additional, Delnoij, Thijs, additional, Lorusso, Roberto, additional, Maas, Jacinta J., additional, Elzo Kraemer, Carlos V., additional, Vlaar, Alexander P.J., additional, Raasveld, S. Jorinde, additional, Donker, Dirk W., additional, Scholten, Erik, additional, Balzereit, Anja, additional, van den Brule, Judith, additional, Kuijpers, Marijn, additional, Vermeulen, Karin M., additional, and van den Bergh, Walter M., additional
- Published
- 2023
- Full Text
- View/download PDF
6. Health-related quality of life, one-year costs and economic evaluation in extracorporeal membrane oxygenation in critically ill adults
- Author
-
Oude Lansink-Hartgring, Annemieke, Miranda, Dinis Dos Reis, Mandigers, Loes, Delnoij, Thijs, Lorusso, Roberto, Maas, Jacinta J., Elzo Kraemer, Carlos V., Vlaar, Alexander P.J., Raasveld, S. Jorinde, Donker, Dirk W., Scholten, Erik, Balzereit, Anja, van den Brule, Judith, Kuijpers, Marijn, Vermeulen, Karin M., van den Bergh, Walter M., Oude Lansink-Hartgring, Annemieke, Miranda, Dinis Dos Reis, Mandigers, Loes, Delnoij, Thijs, Lorusso, Roberto, Maas, Jacinta J., Elzo Kraemer, Carlos V., Vlaar, Alexander P.J., Raasveld, S. Jorinde, Donker, Dirk W., Scholten, Erik, Balzereit, Anja, van den Brule, Judith, Kuijpers, Marijn, Vermeulen, Karin M., and van den Bergh, Walter M.
- Abstract
Purpose: This study reports on survival and health related quality of life (HRQOL) after extracorporeal membrane oxygenation (ECMO) treatment and the associated costs in the first year. Materials and Methods: Prospective observational cohort study patients receiving ECMO in the intensive care unit during August 2017 and July 2019. We analyzed all healthcare costs in the first year after index admission. Follow-up included a HRQOL analysis using the EQ-5D-5L at 6 and 12 months. Results: The study enrolled 428 patients with an ECMO run during their critical care admission. The one-year mortality was 50%. Follow up was available for 124 patients at 12 months. Survivors reported a favorable mean HRQOL (utility) of 0.71 (scale 0–1) at 12 months of 0.77. The overall health status (VAS, scale 0–100) was reported as 73.6 at 12 months. Mean total costs during the first year were $204,513 ± 211,590 with hospital costs as the major factor contributing to the total costs. Follow up costs were $53,752 ± 65,051 and costs of absenteeism were $7317 ± 17,036. Conclusions: At one year after hospital admission requiring ECMO the health-related quality of life is favorable with substantial costs but considering the survival might be acceptable. However, our results are limited by loss of follow up. So it may be possible that only the best-recovered patients returned their questionnaires. This potential bias might lead to higher costs and worse HRQOL in a real-life scenario.
- Published
- 2023
7. Transfusion practice in the bleeding critically ill
- Author
-
de Bruin, Sanne, Eggermont, Dorus, van Bruggen, Robin, de Korte, Dirk, Scheeren, Thomas W.L., Bakker, Jan, Vlaar, Alexander P.J., Abbasciano, Riccardo G., Antonelli, Massimo, Aubron, Cécile, van Baarle, Frank E.H.P., Cecconi, Maurizio, Dionne, Joanna C., Duranteau, Jacques, Gyatt, Gordon, Hunt, Beverley J., Juffermans, Nicole P., Lance, Marcus, Meier, Jens, Muller, Marcella C.A., Murphy, Gavin J., Nielsen, Nathan, Oczkowski, Simon J., Perner, Anders, Raasveld, S. Jorinde, Schöchel, Herbert, Wijnberge, Marije, Critical care, Anesthesiology, Peri-operative and Emergency medicine (CAPE), Pediatric Surgery, Graduate School, ACS - Pulmonary hypertension & thrombosis, AII - Inflammatory diseases, Landsteiner Laboratory, AII - Infectious diseases, Intensive Care Medicine, and ACS - Microcirculation
- Subjects
Critical Illness ,critically ill ,MORTALITY ,Immunology ,FRESH-FROZEN PLASMA ,Hemorrhage ,TRANEXAMIC ACID ,Hematology ,transfusion anemia ,bleeding ,Intensive Care Units ,RED-BLOOD-CELLS ,massive ,RATIO ,Surveys and Questionnaires ,Immunology and Allergy ,Humans ,Blood Transfusion ,coagulation ,Erythrocyte Transfusion ,PROTHROMBIN COMPLEX CONCENTRATE ,REQUIREMENTS ,transfusion ,TRAUMA - Abstract
BACKGROUND: Transfusion is very common in the intensive care unit (ICU), but practice is highly variable, as has recently been shown in non-bleeding critically ill patients practices survey. Bleeding patients in ICU require different blood products across a range of specific patient categories. We hypothesize that a large variety in transfusion practice exists in bleeding patients.STUDY DESIGN AND METHODS: An international online survey was performed among physicians working in the ICU. Transfusion practice in massively and non-massively bleeding patients was examined, including transfusion ratios, thresholds, and the presence of transfusion guidelines.RESULTS: Six hundred eleven respondents filled in the survey of which 401 could be analyzed, representing 64 countries. Among the respondents, 52% had a massive transfusion protocol (MTP) available at their ICU. In massively bleeding patients, 46% of the respondents used fixed transfusion component ratios. Of those who used fixed blood ratios, the 1:1:1 ratio (red blood cell [RBC] concentrates: plasma: platelet concentrates) was most commonly used (33%). The presence of an MTP was associated with a more frequent use of fixed ratios (p DISCUSSION: Half of the centers had no massive transfusion protocol available. Transfusion practice in massively bleeding critically ill patients is highly variable and driven by the presence of an MTP. In the general non-massively bleeding ICU population restrictive transfusion triggers were chosen.
- Published
- 2022
8. Biomarkers of the alcohol hangover state: Ethyl glucuronide (EtG) and ethyl sulfate (EtS)
- Author
-
Mackus, Marlou, van de Loo, Aurora J. A. E., Raasveld, S. Jorinde, Hogewoning, Anna, Sastre Toraño, Javier, Flesch, Frits M., Korte‐Bouws, Gerdien A. H., van Neer, Renier H. P., Wang, Xiaochun, Nguyen, Thomas T., Brookhuis, Karel A., Kraneveld, Aletta D., Garssen, Johan, and Verster, Joris C.
- Published
- 2017
- Full Text
- View/download PDF
9. Reduced anticoagulation targets in extracorporeal life support (RATE): study protocol for a randomized controlled trial.
- Author
-
UCL - SSS/IREC/MEDA - Pôle de médecine aiguë, UCL - (MGD) Services des soins intensifs, van Minnen, Olivier, Oude Lansink-Hartgring, Annemieke, van den Boogaard, Bas, van den Brule, Judith, Bulpa, Pierre, Bunge, Jeroen J H, Delnoij, Thijs S R, Elzo Kraemer, Carlos V, Kuijpers, Marijn, Lambermont, Bernard, Maas, Jacinta J, de Metz, Jesse, Michaux, Isabelle, van de Pol, Ineke, van de Poll, Marcel, Raasveld, S Jorinde, Raes, Matthias, Dos Reis Miranda, Dinis, Scholten, Erik, Simonet, Olivier, Taccone, Fabio S, Vallot, Frederic, Vlaar, Alexander P J, van den Bergh, Walter M, UCL - SSS/IREC/MEDA - Pôle de médecine aiguë, UCL - (MGD) Services des soins intensifs, van Minnen, Olivier, Oude Lansink-Hartgring, Annemieke, van den Boogaard, Bas, van den Brule, Judith, Bulpa, Pierre, Bunge, Jeroen J H, Delnoij, Thijs S R, Elzo Kraemer, Carlos V, Kuijpers, Marijn, Lambermont, Bernard, Maas, Jacinta J, de Metz, Jesse, Michaux, Isabelle, van de Pol, Ineke, van de Poll, Marcel, Raasveld, S Jorinde, Raes, Matthias, Dos Reis Miranda, Dinis, Scholten, Erik, Simonet, Olivier, Taccone, Fabio S, Vallot, Frederic, Vlaar, Alexander P J, and van den Bergh, Walter M
- Abstract
Although life-saving in selected patients, ECMO treatment still has high mortality which for a large part is due to treatment-related complications. A feared complication is ischemic stroke for which heparin is routinely administered for which the dosage is usually guided by activated partial thromboplastin time (aPTT). However, there is no relation between aPTT and the rare occurrence of ischemic stroke (1.2%), but there is a relation with the much more frequent occurrence of bleeding complications (55%) and blood transfusion. Both are strongly related to outcome. We will conduct a three-arm non-inferiority randomized controlled trial, in adult patients treated with ECMO. Participants will be randomized between heparin administration with a target of 2-2.5 times baseline aPTT, 1.5-2 times baseline aPTT, or low molecular weight heparin guided by weight and renal function. Apart from anticoagulation targets, treatment will be according to standard care. The primary outcome parameter is a combined endpoint consisting of major bleeding including hemorrhagic stroke, severe thromboembolic complications including ischemic stroke, and mortality at 6 months. We hypothesize that with lower anticoagulation targets or anticoagulation with LMWH during ECMO therapy, patients will have fewer hemorrhagic complications without an increase in thromboembolic complication or a negative effect on their outcome. If our hypothesis is confirmed, this study could lead to a change in anticoagulation protocols and a better outcome for patients treated with ECMO. ClinicalTrials.gov NCT04536272 . Registered on 2 September 2020. Netherlands Trial Register NL7969.
- Published
- 2022
10. Transfusion practice in the bleeding critically ill:An international online survey—The TRACE-2 survey
- Author
-
de Bruin, Sanne, Eggermont, Dorus, van Bruggen, Robin, de Korte, Dirk, Scheeren, Thomas W.L., Bakker, Jan, Vlaar, Alexander P.J., Abbasciano, Riccardo G., Antonelli, Massimo, Aubron, Cécile, van Baarle, Frank E.H.P., Cecconi, Maurizio, Dionne, Joanna C., Duranteau, Jacques, Gyatt, Gordon, Hunt, Beverley J., Juffermans, Nicole P., Lance, Marcus, Meier, Jens, Muller, Marcella C.A., Murphy, Gavin J., Nielsen, Nathan, Oczkowski, Simon J., Perner, Anders, Raasveld, S. Jorinde, Schöchel, Herbert, Wijnberge, Marije, de Bruin, Sanne, Eggermont, Dorus, van Bruggen, Robin, de Korte, Dirk, Scheeren, Thomas W.L., Bakker, Jan, Vlaar, Alexander P.J., Abbasciano, Riccardo G., Antonelli, Massimo, Aubron, Cécile, van Baarle, Frank E.H.P., Cecconi, Maurizio, Dionne, Joanna C., Duranteau, Jacques, Gyatt, Gordon, Hunt, Beverley J., Juffermans, Nicole P., Lance, Marcus, Meier, Jens, Muller, Marcella C.A., Murphy, Gavin J., Nielsen, Nathan, Oczkowski, Simon J., Perner, Anders, Raasveld, S. Jorinde, Schöchel, Herbert, and Wijnberge, Marije
- Abstract
Background: Transfusion is very common in the intensive care unit (ICU), but practice is highly variable, as has recently been shown in non-bleeding critically ill patients practices survey. Bleeding patients in ICU require different blood products across a range of specific patient categories. We hypothesize that a large variety in transfusion practice exists in bleeding patients. Study design and methods: An international online survey was performed among physicians working in the ICU. Transfusion practice in massively and non-massively bleeding patients was examined, including transfusion ratios, thresholds, and the presence of transfusion guidelines. Results: Six hundred eleven respondents filled in the survey of which 401 could be analyzed, representing 64 countries. Among the respondents, 52% had a massive transfusion protocol (MTP) available at their ICU. In massively bleeding patients, 46% of the respondents used fixed transfusion component ratios. Of those who used fixed blood ratios, the 1:1:1 ratio (red blood cell [RBC] concentrates: plasma: platelet concentrates) was most commonly used (33%). The presence of an MTP was associated with a more frequent use of fixed ratios (p <.001). For RBC transfusion in the general non-massively bleeding ICU population, a hemoglobin (Hb) threshold of 7.0[7.0–7.3] g/dl was reported. In the general ICU population, a platelet count threshold of 50[26–50] × 109/L was applied. Discussion: Half of the centers had no massive transfusion protocol available. Transfusion practice in massively bleeding critically ill patients is highly variable and driven by the presence of an MTP. In the general non-massively bleeding ICU population restrictive transfusion triggers were chosen.
- Published
- 2022
11. Reduced anticoagulation targets in extracorporeal life support (RATE):study protocol for a randomized controlled trial
- Author
-
van Minnen, Olivier, Oude Lansink-Hartgring, Annemieke, van den Boogaard, Bas, van den Brule, Judith, Bulpa, Pierre, Bunge, Jeroen J.H., Delnoij, Thijs S.R., Elzo Kraemer, Carlos V., Kuijpers, Marijn, Lambermont, Bernard, Maas, Jacinta J., de Metz, Jesse, Michaux, Isabelle, van de Pol, Ineke, van de Poll, Marcel, Raasveld, S. Jorinde, Raes, Matthias, dos Reis Miranda, Dinis, Scholten, Erik, Simonet, Olivier, Taccone, Fabio S., Vallot, Frederic, Vlaar, Alexander P.J., van den Bergh, Walter M., van Minnen, Olivier, Oude Lansink-Hartgring, Annemieke, van den Boogaard, Bas, van den Brule, Judith, Bulpa, Pierre, Bunge, Jeroen J.H., Delnoij, Thijs S.R., Elzo Kraemer, Carlos V., Kuijpers, Marijn, Lambermont, Bernard, Maas, Jacinta J., de Metz, Jesse, Michaux, Isabelle, van de Pol, Ineke, van de Poll, Marcel, Raasveld, S. Jorinde, Raes, Matthias, dos Reis Miranda, Dinis, Scholten, Erik, Simonet, Olivier, Taccone, Fabio S., Vallot, Frederic, Vlaar, Alexander P.J., and van den Bergh, Walter M.
- Abstract
Background: Although life-saving in selected patients, ECMO treatment still has high mortality which for a large part is due to treatment-related complications. A feared complication is ischemic stroke for which heparin is routinely administered for which the dosage is usually guided by activated partial thromboplastin time (aPTT). However, there is no relation between aPTT and the rare occurrence of ischemic stroke (1.2%), but there is a relation with the much more frequent occurrence of bleeding complications (55%) and blood transfusion. Both are strongly related to outcome. Methods: We will conduct a three-arm non-inferiority randomized controlled trial, in adult patients treated with ECMO. Participants will be randomized between heparin administration with a target of 2–2.5 times baseline aPTT, 1.5–2 times baseline aPTT, or low molecular weight heparin guided by weight and renal function. Apart from anticoagulation targets, treatment will be according to standard care. The primary outcome parameter is a combined endpoint consisting of major bleeding including hemorrhagic stroke, severe thromboembolic complications including ischemic stroke, and mortality at 6 months. Discussion: We hypothesize that with lower anticoagulation targets or anticoagulation with LMWH during ECMO therapy, patients will have fewer hemorrhagic complications without an increase in thromboembolic complication or a negative effect on their outcome. If our hypothesis is confirmed, this study could lead to a change in anticoagulation protocols and a better outcome for patients treated with ECMO. Trial registration: ClinicalTrials.gov NCT04536272. Registered on 2 September 2020.
- Published
- 2022
12. Incidence and risk factors of deep vein thrombosis after extracorporeal life support
- Author
-
van Minnen, Olivier, primary, van den Bergh, Walter M., additional, Droogh, Joep M., additional, Koehorst, Lisette, additional, Lagrand, Wim K., additional, Raasveld, S. Jorinde, additional, Oude Lansink‐Hartgring, Annemieke, additional, Terpstra, Aart, additional, Smit, Jasper M., additional, Tuinman, Pieter R., additional, and Vlaar, Alexander P. J., additional
- Published
- 2022
- Full Text
- View/download PDF
13. Immune Responses after Heavy Alcohol Consumption: Cytokine Concentrations in Hangover-Sensitive and Hangover-Resistant Drinkers
- Author
-
van de Loo, Aurora Jae, Raasveld, S Jorinde, Hogewoning, Anna, Zeeuw, Raymond de, Bosma, Else R, Bouwmeester, Noor H, Lukkes, Melanie, Knipping, Karen, Mackus, Marlou, Kraneveld, Aletta D, Brookhuis, Karel A, Garssen, Johan, Scholey, Andrew, Verster, Joris C, Afd Pharmacology, dIRAS RA-1, LS communicatie- en informatiewetenschap, Pharmacology, ILS L&C, Afd Pharmacology, dIRAS RA-1, LS communicatie- en informatiewetenschap, Pharmacology, ILS L&C, and Clinical Neuropsychology
- Subjects
Saliva ,Hangover severity ,Leadership and Management ,medicine.medical_treatment ,lcsh:Medicine ,Physiology ,Health Informatics ,Alcohol ,Article ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Immune system ,Health Information Management ,0502 economics and business ,cytokine ,Medicine ,Cytokine ,business.industry ,alcohol ,Health Policy ,lcsh:R ,05 social sciences ,Interleukin ,hangover severity ,immune system ,chemistry ,hangover ,Hangover ,050211 marketing ,Tumor necrosis factor alpha ,Alcohol intake ,business ,Alcohol consumption ,030217 neurology & neurosurgery - Abstract
This study investigated immunological changes during an alcohol hangover, and the possible difference between hangover-resistant and hangover-sensitive drinkers in terms of immune reactivity. Using a semi-naturalistic design, N = 36 healthy social drinkers (18 to 30 years old) provided saliva samples on a control day (after drinking no alcohol) and on a post-alcohol day. Hangover severity was rated directly after saliva collection. Cytokine concentrations, interleukin (IL)-1β, IL-6, IL-8, IL-10 and tumor necrosis factor (TNF)-α, and hangover severity were compared between both test days and between hangover-sensitive and -resistant drinkers. Data from N = 35 drinkers (17 hangover-sensitive and 18 hangover-resistant) were included in the statistical analyses. Relative to the control day, there were significant increases in saliva IL-6 and IL-10 concentrations on the post-alcohol day. No significant differences in cytokine concentrations were found between hangover-sensitive and hangover-resistant drinkers, nor did any change in cytokine concentration correlate significantly with hangover severity. In line with previous controlled studies assessing cytokines in blood, the current naturalistic study using saliva samples also demonstrated that the immune system responds to high-level alcohol intake. However, further research is warranted, as, in contrast to previous findings in blood samples, changes in saliva cytokine concentrations did not differ significantly between hangover-sensitive and hangover-resistant drinkers, nor did they correlate significantly with hangover severity.
- Published
- 2021
- Full Text
- View/download PDF
14. Immune Responses after Heavy Alcohol Consumption: Cytokine Concentrations in Hangover-Sensitive and Hangover-Resistant Drinkers
- Author
-
Afd Pharmacology, dIRAS RA-1, LS communicatie- en informatiewetenschap, Pharmacology, UiL OTS L&C, van de Loo, Aurora Jae, Raasveld, S Jorinde, Hogewoning, Anna, Zeeuw, Raymond de, Bosma, Else R, Bouwmeester, Noor H, Lukkes, Melanie, Knipping, Karen, Mackus, Marlou, Kraneveld, Aletta D, Brookhuis, Karel A, Garssen, Johan, Scholey, Andrew, Verster, Joris C, Afd Pharmacology, dIRAS RA-1, LS communicatie- en informatiewetenschap, Pharmacology, UiL OTS L&C, van de Loo, Aurora Jae, Raasveld, S Jorinde, Hogewoning, Anna, Zeeuw, Raymond de, Bosma, Else R, Bouwmeester, Noor H, Lukkes, Melanie, Knipping, Karen, Mackus, Marlou, Kraneveld, Aletta D, Brookhuis, Karel A, Garssen, Johan, Scholey, Andrew, and Verster, Joris C
- Published
- 2021
15. Biomarkers of the alcohol hangover state: Ethyl glucuronide (EtG) and ethyl sulfate (EtS)
- Author
-
Afd Pharmacology, LS IRAS Tox Algemeen, Afd Chemical Biology and Drug Discovery, Pharmacology, Mackus, Marlou, van de Loo, Aurora J A E, Raasveld, S. Jorinde, Hogewoning, Anna, Sastre Toraño, Javier, Flesch, Frits M, Korte-Bouws, Gerdien A H, van Neer, Renier H P, Wang, Xiaochun, Nguyen, Thomas T, Brookhuis, Karel A, Kraneveld, Aletta D, Garssen, Johan, Verster, Joris C, Afd Pharmacology, LS IRAS Tox Algemeen, Afd Chemical Biology and Drug Discovery, Pharmacology, Mackus, Marlou, van de Loo, Aurora J A E, Raasveld, S. Jorinde, Hogewoning, Anna, Sastre Toraño, Javier, Flesch, Frits M, Korte-Bouws, Gerdien A H, van Neer, Renier H P, Wang, Xiaochun, Nguyen, Thomas T, Brookhuis, Karel A, Kraneveld, Aletta D, Garssen, Johan, and Verster, Joris C
- Published
- 2017
16. IMMUNOLOGICAL AND MOOD CHANGES THE DAY AFTER HEAVY ALCOHOL CONSUMPTION: A COMPARISON OF DRINKERS WITH A HANGOVER VERSUS THOSE WHO CLAIM HANGOVER RESISTANCE
- Author
-
Van De Loo, Aurora J. A. E., Hogewoning, Anna, Raasveld, S. Jorinde, De Zeeuw, Raymond, Bosma, Else R., Bouwmeester, Noor H., Lukkes, Melanie, Brookhuis, Karel A., Knipping, Karen, Garssen, Johan, Verster, Joris C., and Clinical Neuropsychology
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.